APA (7th ed.) Citation

Kobayashi, K., Wakatsuki, T., Sugiyama, E., Shinozaki, E., Tajima, M., Ogura, M., . . . Yamaguchi, K. (2025). Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC. CTS: Clinical & Translational Science, 18(11), 1. https://doi.org/10.1111/cts.70386

Chicago Style (17th ed.) Citation

Kobayashi, Kazuo, et al. "Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With MCRC." CTS: Clinical & Translational Science 18, no. 11 (2025): 1. https://doi.org/10.1111/cts.70386.

MLA (9th ed.) Citation

Kobayashi, Kazuo, et al. "Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With MCRC." CTS: Clinical & Translational Science, vol. 18, no. 11, 2025, p. 1, https://doi.org/10.1111/cts.70386.